LEXISCAN(R) (REGADENOSON)

FDA Drug Profile — LEXISCAN(R) (REGADENOSON)

LEXISCAN(R) (REGADENOSON) is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including LEXISCAN(R) (REGADENOSON). Available dosage form: injection, solution.

Drug details

Generic Name
LEXISCAN(R) (REGADENOSON)
Brand Names
LEXISCAN(R) (REGADENOSON)
Application Number
NDA022161
Sponsor
HF Acquisition Co LLC, DBA HealthFirst
NDC Codes
1
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients
REGADENOSON

Indications and Usage

1 INDICATIONS & USAGE LEXISCAN® (regadenoson) injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.